Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

The tool is said to predict “off-target” effects for seven drugs that could aid in cellular hypertrophy prevention.

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025Upon FDA approval, ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...

Eugene 'Big U' Henley helped launch Nipsey Hussle's career and was called rap's 'godfather' by Wiz Khalifa. Now federal ...

Heavily redacted court documents are shedding no fresh light on the circumstances under which Prince Harry entered the United ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), has concluded the Technology Adoption ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

The Technology Adoption Program successfully tested the ability of the Bridgewater Smart Factory to automate, lower costs and ...

Completed strategic review to focus on oncology and liver diseases with the acquisition of global rights to GB3226 (formerly BRM-1420), a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets ...